BioMime Vs. Xience Randomised Control Clinical Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
meriT-V is a Prospective,active control open lable clinical trial to compare safety \& efficacy of BioMime Sirolimus stent Vs. Xience family of Everolimus stent by random assignment for treatment of coronary artery disease at multiple multinational centres.
Epistemonikos ID: 4375a0194896cc636ce5e01273155b5460d7e694
First added on: May 11, 2024